Copyright Reports & Markets. All rights reserved.

Global Ubiquitin Enzymes Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Ubiquitin Enzymes Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 E1 and E2 Enzymes as Therapeutic Targets
      • 1.4.3 E3 Enzymes as Therapeutic Tragets
      • 1.4.4 Dub Enzymes as therapeutic Tragets
      • 1.4.5 Associated Drug Classes
    • 1.5 Market by Application
      • 1.5.1 Global Ubiquitin Enzymes Market Share by Application (2014-2025)
      • 1.5.2 Cancer
      • 1.5.3 Biological Engineering
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Ubiquitin Enzymes Market Size
    • 2.2 Ubiquitin Enzymes Growth Trends by Regions
      • 2.2.1 Ubiquitin Enzymes Market Size by Regions (2014-2025)
      • 2.2.2 Ubiquitin Enzymes Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Ubiquitin Enzymes Market Size by Manufacturers
      • 3.1.1 Global Ubiquitin Enzymes Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Ubiquitin Enzymes Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Ubiquitin Enzymes Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ubiquitin Enzymes Key Players Head office and Area Served
    • 3.3 Key Players Ubiquitin Enzymes Product/Solution/Service
    • 3.4 Date of Enter into Ubiquitin Enzymes Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Ubiquitin Enzymes Market Size by Type (2014-2019)
    • 4.2 Global Ubiquitin Enzymes Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Ubiquitin Enzymes Market Size (2014-2019)
    • 5.2 Ubiquitin Enzymes Key Players in United States
    • 5.3 United States Ubiquitin Enzymes Market Size by Type
    • 5.4 United States Ubiquitin Enzymes Market Size by Application

    6 Europe

    • 6.1 Europe Ubiquitin Enzymes Market Size (2014-2019)
    • 6.2 Ubiquitin Enzymes Key Players in Europe
    • 6.3 Europe Ubiquitin Enzymes Market Size by Type
    • 6.4 Europe Ubiquitin Enzymes Market Size by Application

    7 China

    • 7.1 China Ubiquitin Enzymes Market Size (2014-2019)
    • 7.2 Ubiquitin Enzymes Key Players in China
    • 7.3 China Ubiquitin Enzymes Market Size by Type
    • 7.4 China Ubiquitin Enzymes Market Size by Application

    8 Japan

    • 8.1 Japan Ubiquitin Enzymes Market Size (2014-2019)
    • 8.2 Ubiquitin Enzymes Key Players in Japan
    • 8.3 Japan Ubiquitin Enzymes Market Size by Type
    • 8.4 Japan Ubiquitin Enzymes Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Ubiquitin Enzymes Market Size (2014-2019)
    • 9.2 Ubiquitin Enzymes Key Players in Southeast Asia
    • 9.3 Southeast Asia Ubiquitin Enzymes Market Size by Type
    • 9.4 Southeast Asia Ubiquitin Enzymes Market Size by Application

    10 India

    • 10.1 India Ubiquitin Enzymes Market Size (2014-2019)
    • 10.2 Ubiquitin Enzymes Key Players in India
    • 10.3 India Ubiquitin Enzymes Market Size by Type
    • 10.4 India Ubiquitin Enzymes Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Ubiquitin Enzymes Market Size (2014-2019)
    • 11.2 Ubiquitin Enzymes Key Players in Central & South America
    • 11.3 Central & South America Ubiquitin Enzymes Market Size by Type
    • 11.4 Central & South America Ubiquitin Enzymes Market Size by Application

    12 International Players Profiles

    • 12.1 3SBio
      • 12.1.1 3SBio Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Ubiquitin Enzymes Introduction
      • 12.1.4 3SBio Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.1.5 3SBio Recent Development
    • 12.2 5AM Ventures
      • 12.2.1 5AM Ventures Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Ubiquitin Enzymes Introduction
      • 12.2.4 5AM Ventures Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.2.5 5AM Ventures Recent Development
    • 12.3 Abbiotec
      • 12.3.1 Abbiotec Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Ubiquitin Enzymes Introduction
      • 12.3.4 Abbiotec Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.3.5 Abbiotec Recent Development
    • 12.4 Abcam
      • 12.4.1 Abcam Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Ubiquitin Enzymes Introduction
      • 12.4.4 Abcam Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.4.5 Abcam Recent Development
    • 12.5 AcelRx Pharmaceuticals
      • 12.5.1 AcelRx Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Ubiquitin Enzymes Introduction
      • 12.5.4 AcelRx Pharmaceuticals Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.5.5 AcelRx Pharmaceuticals Recent Development
    • 12.6 Aegera Therapeutics
      • 12.6.1 Aegera Therapeutics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Ubiquitin Enzymes Introduction
      • 12.6.4 Aegera Therapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.6.5 Aegera Therapeutics Recent Development
    • 12.7 Aeneas Ventures
      • 12.7.1 Aeneas Ventures Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Ubiquitin Enzymes Introduction
      • 12.7.4 Aeneas Ventures Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.7.5 Aeneas Ventures Recent Development
    • 12.8 Agilis Biotherapeutics
      • 12.8.1 Agilis Biotherapeutics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Ubiquitin Enzymes Introduction
      • 12.8.4 Agilis Biotherapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.8.5 Agilis Biotherapeutics Recent Development
    • 12.9 Aileron Therapeutics
      • 12.9.1 Aileron Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Ubiquitin Enzymes Introduction
      • 12.9.4 Aileron Therapeutics Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.9.5 Aileron Therapeutics Recent Development
    • 12.10 Aju IB Investment
      • 12.10.1 Aju IB Investment Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Ubiquitin Enzymes Introduction
      • 12.10.4 Aju IB Investment Revenue in Ubiquitin Enzymes Business (2014-2019)
      • 12.10.5 Aju IB Investment Recent Development
    • 12.11 Alexion Pharmaceuticals
    • 12.12 Almac Discovery
    • 12.13 Amgen
    • 12.14 Angelman Syndrome Foundation
    • 12.15 Apeiron Biologics
    • 12.16 Boston Biochem
    • 12.17 Boston University Technology Development Fund
    • 12.18 BostonBiochem
    • 12.19 BPS Biosciences
    • 12.20 Business Development Bank of Canada
    • 12.21 Business Development Corporation (BDC) Capital
    • 12.22 C4 Therapeutics
    • 12.23 Calculus Capital
    • 12.24 Canaan Partners
    • 12.25 Cancer Research Technology
    • 12.26 Captor Therapeutics
    • 12.27 Carmot Therapeutics
    • 12.28 Cayman Chemicals
    • 12.29 Celgene Corporation
    • 12.30 Cell Signaling Technology

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Ubiquitin Enzymes market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Ubiquitin Enzymes status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ubiquitin Enzymes development in United States, Europe and China.

      The key players covered in this study
      3SBio
      5AM Ventures
      Abbiotec
      Abcam
      AcelRx Pharmaceuticals
      Aegera Therapeutics
      Aeneas Ventures
      Agilis Biotherapeutics
      Aileron Therapeutics
      Aju IB Investment
      Alexion Pharmaceuticals
      Almac Discovery
      Amgen
      Angelman Syndrome Foundation
      Apeiron Biologics
      Boston Biochem
      Boston University Technology Development Fund
      BostonBiochem
      BPS Biosciences
      Business Development Bank of Canada
      Business Development Corporation (BDC) Capital
      C4 Therapeutics
      Calculus Capital
      Canaan Partners
      Cancer Research Technology
      Captor Therapeutics
      Carmot Therapeutics
      Cayman Chemicals
      Celgene Corporation
      Cell Signaling Technology

      Market segment by Type, the product can be split into
      E1 and E2 Enzymes as Therapeutic Targets
      E3 Enzymes as Therapeutic Tragets
      Dub Enzymes as therapeutic Tragets
      Associated Drug Classes

      Market segment by Application, split into
      Cancer
      Biological Engineering
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Ubiquitin Enzymes status, future forecast, growth opportunity, key market and key players.
      To present the Ubiquitin Enzymes development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Ubiquitin Enzymes are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now